Innorna Was Listed on The "2023 Top 100 Startups" by China Entrepreneur Magazine

Recently, the China Entrepreneur Magazine released the "2023 Top 100 Startups" list, in which Innorna has successfully earned its place with its world-leading nucleic acids delivery technology platform, consistent technological innovation capabilities, outstanding external cooperation achievements, and huge growth potential.

The "Top 100 Startups" list focuses on unlisted Chinese companies that have been founded within 10 years, and have a market capitalization of more than 3 billion yuan. The aim is to identify companies that are expected to grow rapidly and may lead the future of the industry among the vast number of startups.

This selection was based on the recommendations of investment institutions and expert panels. It considered quantitative indicators such as company valuation, financing rounds, and total financing size. It selected 100 emerging companies in 16 industries from tens of thousands of companies, including big chips/semiconductors, biopharmaceutical, advanced manufacturing, new energy, new consumption, etc. A total of 12 companies in the biopharmaceutical field were selected, and Innorna was honored among them.